• Tuesday, Aug 09, 2022
  • Last Update : 04:24 pm

India will allow some exports of anti-malaria drug after Trump appeal

  • Published at 12:20 pm April 7th, 2020
malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19)
File photo: Researchers at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020 Reuters

The Indian government had earlier put a hold on exports of hydroxychloroquine as well as on the pain reliever, paracetamol

India will allow some exports of the anti-malaria drug hydroxychloroquine, the foreign ministry said on Tuesday, after US President Donald Trump urged New Delhi to release supplies of the drug seen as a possible treatment for Covid-19.

The Indian government had earlier put a hold on exports of hydroxychloroquine as well as on the pain reliever, paracetamol, saying it had to meet its internal demand. But Trump spoke to Prime Minister Narendra Modi over the weekend seeking supplies and later hinted that India may face retaliation.

"It has been decided that India would license paracetamol and HCQ in appropriate quantities to all our neighboring countries who are dependent on our capabilities," said Indian foreign ministry spokesman, Anurag Srivastava.

"We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic," he said.